Submitted by Anonymous (not verified) on 4 August 2023 - 12:24
Human medicines European public assessment report (EPAR): Erelzi, etanercept, Arthritis, Psoriatic;Psoriasis;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid;Spondylitis, Ankylosing, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised
Source: